Decision Making, Shared, Pregnancy, Preterm Birth
Conditions
Keywords
Antenatal corticosteroid
Brief summary
The purpose of this study is to find out if including a decision support tool in clinical practice guidelines will improve how doctors discuss the option of antenatal corticosteroid treatment with patients who might deliver at 34 to 36 weeks of pregnancy.
Interventions
BEHAVIORALDecision support tool
Decision support tool for late preterm antenatal corticosteroids
Sponsors
Canadian Institutes of Health Research (CIHR)
University of British Columbia
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Intervention model description
Controlled before and after study
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age 18 year or older. * Delivered a live neonate at 34+0 to 36+6 weeks of gestation. * Speaks English. * Agrees to participate in the questionnaire during their first week post-partum. * Delivered at one of the six participating obstetrical hospitals.
Exclusion criteria
* None.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The change in frequency of clinical counselling about late preterm antenatal corticosteroids. | up to 8 months following implementation of the intervention. | The difference in the proportion of patients who delivered a neonate at 34+0 to 36+6 weeks' gestation who report having had a discussion about antenatal corticosteroids with their care provider pre-intervention versus post-intervention. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The change in quality of clinical counselling about late preterm antenatal corticosteroids as assessed by the COMRADE scale. | up to 8 months following implementation of the intervention. | The difference in the average median score on the Combined Outcome Measure for Risk Communication and Treatment Decision Making Effectiveness (COMRADE) scale, among those that report having had a discussion about late preterm antenatal corticosteroids with their health care provider. We will use an adapted scale including 19 items, each of which are scored on a 5-point Likert scale. A higher score indicates better risk communication and treatment decision making effectiveness. |
Countries
Canada
Contacts
Primary ContactJessica Liauw, MD
Outcome results
None listed